PEDIATRICS Vol. 80 No. 5 November 1987, pp. 758-760
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation

Medication for Children With an Attention Deficit Disorder

Committee on Children With Disabilities and Committee on Drugs

BACKGROUND

In 1975, the AAP Council1 on Child Health issued a statement on medication for hyperkinetic children. Since that time, the nomenclature for such disorders has changed, as has the knowledge and usage of the medications involved. In this statement the role of medications for hyperactive children is reviewed in light of current nosology.

In recent years, the term "attention deficit disorder" has become established as a recognized diagnostic category with three major subtypes: (1) attention deficit disorder with hyperactivity, (2) attention deficit disorder without hyperactivity, and (3) attention deficit disorder residual.2 In 1987, the American Psychiatric Association2 adopted the new, inclusive term, attention deficit hyperactivity disorder.

Some clinicians and authors imply that the educational problems in these children are caused by their attention deficit.3 Although attention deficit disorder may infrequently occur in isolation, it is more commonly manifested as one of a series of symptoms associated with disorders of higher cortical functioning that include disturbances in movement, cognition, communication, and social competence.

Many educators and physicians do not realize that a differential diagnosis exists for these behaviors much as it does for any other complex of symptoms. To establish an accurate diagnosis, information must be obtained on factors such as: (1) the child's birth, developmental, family, medical, psychosocial, and scholastic history; (2) sensory screening (ie, vision and hearing), and (3) a physical, neurologic, and neuromaturational examination.

As was originally stated by the Council on Child Health,1

The use of drug therapy in the management of the hyperkinetic child does not differ appreciably from drug therapy in other treatable maladies.


The following policy statement is a revision:

Medication for Children With Attentional Disorders
and
Pediatrics 98: 301-304.



This article has been cited by other articles:


Home page
 Psychiatr. Serv.Home page
R. Bussing, B. T. Zima, F. A. Gary, and C. W. Garvan
Use of Complementary and Alternative Medicine for Symptoms of Attention-Deficit Hyperactivity Disorder
Psychiatr Serv, September 1, 2002; 53(9): 1096 - 1102.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
E. Lahat, M. Weiss, A. Ben-Shlomo, S. Evans, and T. Bistritzer
Bone Mineral Density and Turnover in Children With Attention-Deficit Hyperactivity Disorder Receiving Methylphenidate
J Child Neurol, July 1, 2000; 15(7): 436 - 439.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. R. Rosh, S. F. Dellert, M. Narkewicz, A. Birnbaum, and G. Whitington
Four Cases of Severe Hepatotoxicity Associated With Pemoline: Possible Autoimmune Pathogenesis
Pediatrics, May 1, 1998; 101(5): 921 - 923.
[Full Text] [PDF]

Home page
 PediatricsHome page
D. Efron, F. Jarman, and M. Barker
Methylphenidate Versus Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial
Pediatrics, December 1, 1997; 100(6): e6 - e6.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
D. A. Kube and B. K. Shapiro
Persistent School Dysfunction: Unrecognized Comorbidity and Suboptimal Therapy
Clinical Pediatrics, November 1, 1996; 35(11): 571 - 576.
[Abstract] [PDF]

Home page
 CLIN PEDIATRHome page
L. Rebecca Campbell and M. Cohen
Management of Attention Deficit Hyperactivity Disorder (ADHD): A Continuing Dilemma for Physicians and Educators
Clinical Pediatrics, March 1, 1990; 29(3): 191 - 193.
[Abstract] [PDF]